324 related articles for article (PubMed ID: 34044100)
1. Antimicrobial susceptibility profiles of invasive isolates of anaerobic bacteria from a large Canadian reference laboratory: 2012-2019.
Forbes JD; Kus JV; Patel SN
Anaerobe; 2021 Aug; 70():102386. PubMed ID: 34044100
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial susceptibility of clinical isolates of anaerobic bacteria in Ontario, 2010-2011.
Marchand-Austin A; Rawte P; Toye B; Jamieson FB; Farrell DJ; Patel SN
Anaerobe; 2014 Aug; 28():120-5. PubMed ID: 24923267
[TBL] [Abstract][Full Text] [Related]
3. High rate of non-susceptibility to metronidazole and clindamycin in anaerobic isolates: Data from a clinical laboratory from Karachi, Pakistan.
Sheikh SO; Jabeen K; Qaiser S; Ahsan ST; Khan E; Zafar A
Anaerobe; 2015 Jun; 33():132-6. PubMed ID: 25800668
[TBL] [Abstract][Full Text] [Related]
4. Geographic patterns of antimicrobial susceptibilities for Bacteroides spp. worldwide: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) programme, 2007-2020.
Wu PH; Chen CH; Lin HH; Tseng KH; Ko WC; Ho MW; Hsueh PR
Int J Antimicrob Agents; 2023 Jul; 62(1):106822. PubMed ID: 37088437
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of anaerobic bacteria in Auckland: 1991-1996.
Shore KP; Pottumarthy S; Morris AJ
N Z Med J; 1999 Nov; 112(1099):424-6. PubMed ID: 10678225
[TBL] [Abstract][Full Text] [Related]
6. Comparative susceptibility of the Bacteroides fragilis group species and other anaerobic bacteria to meropenem, imipenem, piperacillin, cefoxitin, ampicillin/sulbactam, clindamycin and metronidazole.
Goldstein EJ; Citron DM; Cherubin CE; Hillier SL
J Antimicrob Chemother; 1993 Mar; 31(3):363-72. PubMed ID: 8486570
[TBL] [Abstract][Full Text] [Related]
7. [Identification of anaerobic bacteria isolated from various clinical specimens and determination of antibiotic susceptibilities].
Doğan M; Baysal B
Mikrobiyol Bul; 2010 Apr; 44(2):211-9. PubMed ID: 20549955
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial Susceptibility Patterns of Anaerobic Bacterial Clinical Isolates From 2014 to 2016, Including Recently Named or Renamed Species.
Byun JH; Kim M; Lee Y; Lee K; Chong Y
Ann Lab Med; 2019 Mar; 39(2):190-199. PubMed ID: 30430782
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial susceptibility of clinically isolated anaerobic bacteria in a University Hospital Centre Split, Croatia in 2013.
Novak A; Rubic Z; Dogas V; Goic-Barisic I; Radic M; Tonkic M
Anaerobe; 2015 Feb; 31():31-6. PubMed ID: 25479237
[TBL] [Abstract][Full Text] [Related]
10. Surveillance and trends of antimicrobial resistance among clinical isolates of anaerobes in Kuwait hospitals from 2002 to 2007.
Jamal W; Shahin M; Rotimi VO
Anaerobe; 2010 Feb; 16(1):1-5. PubMed ID: 19406247
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial susceptibility of anaerobic bacteria in New Zealand: 1999-2003.
Roberts SA; Shore KP; Paviour SD; Holland D; Morris AJ
J Antimicrob Chemother; 2006 May; 57(5):992-8. PubMed ID: 16507560
[TBL] [Abstract][Full Text] [Related]
12. Susceptibilities of 428 gram-positive and -negative anaerobic bacteria to Bay y3118 compared with their susceptibilities to ciprofloxacin, clindamycin, metronidazole, piperacillin, piperacillin-tazobactam, and cefoxitin.
Pankuch GA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1993 Aug; 37(8):1649-54. PubMed ID: 8215278
[TBL] [Abstract][Full Text] [Related]
13. High incidence of cefoxitin and clindamycin resistance among anaerobes in Taiwan.
Teng LJ; Hsueh PR; Tsai JC; Liaw SJ; Ho SW; Luh KT
Antimicrob Agents Chemother; 2002 Sep; 46(9):2908-13. PubMed ID: 12183246
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility of anaerobic bacteria to nine antimicrobial agents and demonstration of decreased susceptibility of Clostridium perfringens to penicillin.
Marrie TJ; Haldane EV; Swantee CA; Kerr EA
Antimicrob Agents Chemother; 1981 Jan; 19(1):51-5. PubMed ID: 6264842
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of tigecycline and comparators against a European collection of anaerobes collected as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) 2010-2016.
Rodloff AC; Dowzicky MJ
Anaerobe; 2018 Jun; 51():78-88. PubMed ID: 29679648
[TBL] [Abstract][Full Text] [Related]
16. Genetic identification and antimicrobial susceptibility of clinically isolated anaerobic bacteria: A prospective multicenter surveillance study in Japan.
Yunoki T; Matsumura Y; Yamamoto M; Tanaka M; Hamano K; Nakano S; Noguchi T; Nagao M; Ichiyama S;
Anaerobe; 2017 Dec; 48():215-223. PubMed ID: 28935196
[TBL] [Abstract][Full Text] [Related]
17. Surveillance of antimicrobial resistance in recent clinical isolates of Gram-negative anaerobic bacteria in a Greek University Hospital.
Maraki S; Mavromanolaki VE; Stafylaki D; Kasimati A
Anaerobe; 2020 Apr; 62():102173. PubMed ID: 32062399
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility patterns of clinically significant Gram-positive anaerobic bacteria in a Greek tertiary-care hospital, 2017-2019.
Maraki S; Mavromanolaki VE; Stafylaki D; Kasimati A
Anaerobe; 2020 Aug; 64():102245. PubMed ID: 32707228
[TBL] [Abstract][Full Text] [Related]
19. The European committee on antimicrobial susceptibility testing disc diffusion susceptibility testing method for frequently isolated anaerobic bacteria.
Matuschek E; Copsey-Mawer S; Petersson S; Åhman J; Morris TE; Kahlmeter G
Clin Microbiol Infect; 2023 Jun; 29(6):795.e1-795.e7. PubMed ID: 36746258
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility of anaerobic bacteria to antimicrobial agents.
Collignon PJ; Munro R; Morris G
Pathology; 1988 Jan; 20(1):48-52. PubMed ID: 3374973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
